These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12373040)

  • 1. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitivity in women with coronary heart disease during hormone replacement therapy.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    J Womens Health (Larchmt); 2005 Mar; 14(2):137-45. PubMed ID: 15775731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
    Koh KK; Bui MN; Mincemoyer R; Cannon RO
    Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins.
    Os I; Hofstad AE; Brekke M; Abdelnoor M; Nesheim BI; Jacobsen AF; Birkeland K; Larsen A; Midtbo K; Westheim A
    J Intern Med; 2000 Apr; 247(4):433-41. PubMed ID: 10792556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.
    Djurovic S; Os I; Hofstad AE; Abdelnoor M; Westheim A; Berg K
    J Intern Med; 2000 Feb; 247(2):279-85. PubMed ID: 10692092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women.
    Ventura P; Cagnacci A; Malmusi S; Panini R; Baldassari F; Arangino S; Volpe A; Salvioli G
    Menopause; 2001; 8(4):252-8. PubMed ID: 11449082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
    Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M
    Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, coronary artery disease, and hormones.
    Lobo RA
    Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
    Kurtay G; Ozmen B
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease.
    Seljeflot I; Arnesen H; Hofstad AE; Os I
    Thromb Haemost; 2000 Jun; 83(6):944-8. PubMed ID: 10896253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
    Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
    Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
    Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating transforming growth factor-beta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease.
    Bogavac-Stanojevic N; Djurovic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Kalimanovska-Ostric D
    Clin Chem Lab Med; 2003 Jul; 41(7):893-8. PubMed ID: 12940514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.